Power Law company profile

Ikaria

Biotech & Life Sciences · Hampton Township, United States · Founded 2007 Unicorn

Develop and deliver innovative therapeutics and interventions to meet the significant needs of critically

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

6 investors on Ikaria's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Venrock

ARCH Venture Partners

5AM Ventures

Aravis Ventures

Series B+ 2 investors entered at this stage

Black Point Group

New Mountain Capital

Global footprint

Where Ikaria has talent and traffic

Workforce by country

6 countries with
team presence

🇺🇸 United States44.4%

🇩🇰 Denmark11.1%

🇨🇦 Canada11.1%

🇵🇱 Poland11.1%

🇸🇰 Slovakia11.1%

Top 5 of 6 shown

Patent intelligence

$134M patent portfolio · 43 active families

Estimated portfolio value

$134M

52.8× smaller than top peer Janssen Vaccines ($7.1B)

43 active patent families

Where Ikaria innovates Intensive care medicineDrugPharmacologyNitric oxideDelivery system

Where Ikaria concentrates vs peers

Each axis is a top-10 topic across Ikaria and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ikaria

An AI-synthesized read of the highest-engagement posts about Ikaria on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ikaria on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles